Medistim

Regulatory Filings • Oct 31, 2023

Medistim is opening a direct sales office in Sweden

Medistim is opening a direct sales office in Sweden

Oslo, October 31, 2023) Medistim ASA (OSE: MEDI) is a niche market leader in

ultrasound technology, headquartered in Oslo, Norway. The company develops and

commercializes medical equipment for use in Cardiac, Vascular, and Transplant

surgery. Today, Medistim announce that they are expanding their market coverage

in Sweden by establishing a direct sales office, opening today. This move is part

of the company's ongoing commitment to providing exceptional service to

customers as well as fulfilling the company’s global growth strategy.

The company is well positioned to continue its growth by further developing the conversion from devices with Transit Time Flow Measurement (TTFM) technology only, to devices combining TTFM and High-Frequency Ultrasound (HFUS). In addition, the company have established exclusive distribution agreement with the Austrian manufacturer Agency for Medical Innovations (A.M.I.) with their product portfolio in urology, coloproctology and urogynecology. Medistim already has the rights for A.M.I. products in Norway and Denmark. With a direct presence in these three countries, Medistim is positioned to build a broader, Scandinavian distribution business.

The new subsidiary, Medistim Sverige AB, is a subsidiary of Medistim Norge AS, and

will be managed by Ole Jørgen Robsrud, Managing Director for Norway and Denmark.

Medistim take the opportunity to acknowledge and appreciate the longstanding and

successful collaboration with Vingmed AB since 1994. Vingmed have established the Medistim brand from scratch to become the recognized standard of care in cardiac, vascular and transplant surgery in Sweden that it is today.

"We are excited to take this step forward with our direct sales in Sweden, strengthening our relationship with our customers and also opening up for building a stronger Scandinavian third-party distribution business," says Medistim President and CEO Kari E. Krogstad.

About Medistim:

Medistim was established in 1984 and has a track record of profitable growth

over the past 20 years. The company is a pioneer within its segment and

continues to invest in new product development. Medistim has wholly owned

subsidiaries with sales organizations in the USA, Canada, China, Germany, the

UK, Spain, Denmark, Sweden and Norway, in addition to around 60 distributors in Europe, Asia, the Middle East, Africa, and South America.

For more information, visit the Medistim home page: www.medistim.com

For more information, contact:

President and CEO, Kari E. Krogstad, Medistim ASA

Tel: + 47 918 38 110

Email: kari.krogstad@medistim.com

CFO, Thomas Jakobsen, Medistim ASA

Tel: + 47 906 59 940

Email: thomas.jakobsen@medistim.com